Filter
407
Text search:
metaanalysis
Featured
Recommendations
46
New Publications
50
Language
Document type
No document type
180
Guidelines
94
Studies & Reports
84
Fact sheets
19
Manuals
12
Strategic & Response Plan
7
Resource Platforms
6
Training Material
2
Situation Updates
2
Infographics
1
Countries / Regions
Global
24
Russia
13
Western and Central Europe
11
India
9
Germany
9
Latin America and the Carribbean
8
Kenya
6
Brazil
6
Middle East and North Africa
6
Africa
6
South Africa
5
Eastern Europe
4
Nigeria
3
Ethiopia
3
Indonesia
3
Malawi
3
Mozambique
3
Argentina
3
Peru
3
East and Southern Africa
3
Asia
3
Burkina Faso
2
Congo, Democratic Republic of
2
Cameroon
2
Uganda
2
Philippines
2
Syria
2
Ukraine
2
Angola
2
Chile
2
Yemen
2
West and Central Africa
2
Eastern Europe and Central Asia
2
Estonia
2
Sierra Leone
1
Senegal
1
Guinea-Bissau
1
USA
1
Ghana
1
Zimbabwe
1
Afghanistan
1
Zambia
1
Tanzania
1
Cambodia
1
Singapore
1
Sudan
1
Namibia
1
Burundi
1
Ecuador
1
Guatemala
1
Madagascar
1
Other region
1
Palestine
1
Southern Africa
1
Canada
1
North America
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
82
Clinical Guidelines
58
Women & Child Health
29
Public Health
25
Key Resources
4
Pharmacy & Technologies
4
Capacity Building
1
Toolboxes
Mental Health
93
COVID-19
69
HIV
46
TB
36
NCDs
24
Planetary Health
15
Caregiver
13
AMR
12
Refugee
8
Disability
5
NTDs
5
Polio
3
Global Health Education
3
Ebola
2
Conflict
2
Rapid Response
2
Pharmacy
2
Health Financing Toolbox
2
Zika
1
Specific Hazards
1
PLoS ONE 12(7): e0180996. https://doi.org/10.1371/journal.pone.0180996
Research Article
BMC Infectious Diseases 2014, 14:91/1471-2334/14/91
PLOS ONE | DOI:10.1371/journal.pone.0142290 November 9, 2015; 1 / 16
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported
...
Research
BMJ 2014;349:g4643 doi: 10.1136/bmj.g4643 (Published 5 August 2014), 1-11
Chen et al. BMC Public Health 2014, 14:776 http://www.biomedcentral.com/1471-2458/14/776
Intensive Care Med (2009) 35:9–29DOI 10.1007/s00134-008-1336-9
Although thousands of papers have been devoted tohospital-acquired pneumonia (HAP), many controversiesremain, and management of HAP is probably often sub-optimal. Several reviews or guidelines have been pub-lished rec
...
Journal of Child Psychology and Psychiatry60:5 (2019), pp 500–515
Q 1: Are antidepressants (Tricyclic Antidepressants (TCA) and Selective Serotonin Reuptake Inhibitors (SSRI)) better (more
effective than/as safe as) than treatment as usual (placebo) in adults with depressive episode/disorder?
Q 2: How long should treatment with antidepressants continue in adults with depressive episode/disorder?
This report includes analysis from informal regional consultations in the African Region, the Caribbean and North America, Latin America, South-East Asia Region, European Region, Eastern Mediterranean Region, alongside three forums in the Western Pacific Region. It analyses the overarching similarit
...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen
...
Q 3: Is brief, structured psychological treatment in non-specialist health care settings better (more effective than/as safe as) than treatment as usual in people with depressive episode/disorder?
These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource implications, and patient values and preferences.
The 2018 edition of the guidelines includes the re
...
Guidelines for Management and Treatment of Dyslipidemia in Indonesia
